Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2377
Source ID: NCT04439474
Associated Drug: Vitamin D3
Title: Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Vitamin D3|DRUG: Routine treatment
Outcome Measures: Primary: Vitamin D serum levels, Vitamin D serum levels measured by blood tests, up to 1 year|Triglyceride, Level of blood triglycerides measured by a blood test, up to 1 year|Blood cholesterol levels, Blood cholesterol levels measured by a blood test, up to 1 year|HDL, Blood HDL levels measured by a blood test, up to 1 year|LDL, Blood LDL levels measured by a blood test, up to 1 year|Fasting blood glucose, Fasting blood glucose levels measured by a blood test, up to 1 year|Neuropathy, Neuropathy based on United Kingdom Screening TEST, up to 1 year|Nephropathy, Nephropathy based on albumin excretion evaluation, up to 1 year|Retinopathy, Retinopathy based on an ophthalmologist's examination, up to 1 year|blood pressure, Systolic and diastolic blood pressure measured by Sphygmomanometer, up to 1 year|HBA1C, Blood sugar levels measured in the last three months measured by blood test, up to 1 year |
Sponsor/Collaborators: Sponsor: Baqiyatallah Medical Sciences University
Gender: ALL
Age: CHILD, ADULT, OLDER_ADULT
Phases:
Enrollment: 187
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2018-10-10
Completion Date: 2020-02-10
Results First Posted:
Last Update Posted: 2020-06-19
Locations: Mohammad Sadegh Bagheri Baghdasht, Tehran, 0, Iran, Islamic Republic of
URL: https://clinicaltrials.gov/show/NCT04439474